[1]
Abreu, N.K. et al. 2021. 5-YEAR SURVIVAL ACCORDING TO THE MOLECULAR SUBTYPE OF 9,516 BREAST CANCER PATIENTS TREATED IN A REFERENCE CENTER. Mastology. 31, (Aug. 2021), 56.